English

LARGE SCALE BIOLOGY CORP

EDGAR

Quarterly report (10-Q) · filed 2005-11-18

23 filing records in this dataset, filed from 2000-11-14 to 2005-11-18. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.1 million USD

2005-09-30 · USD

Exact inputs and evidence

Revenue: 1097000 USD Source

Operating margin

-247.22%

2005-09-30 · %

Exact inputs and evidence

Operating Income: -2712000 USD Source
Revenue: 1097000 USD Source

Operating cash flow

-1.28 million USD

2005-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -7406000 USD Source
Operating Cash Flow: -6129000 USD Source

Free cash flow

-1.29 million USD

2005-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -7406000 USD Source
Operating Cash Flow: -6129000 USD Source
Capital Expenditure: 151000 USD Source
Capital Expenditure: 136000 USD Source

Cash and cash equivalents: 85 thousand USD 2005-09-30 Source
Exact value

85000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.77 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Revenue: 1767000 USD · 2004-01-01 – 2004-12-31 Source
Revenue: 1204000 USD · 2004-01-01 – 2004-09-30 Source
Revenue: 433000 USD · 2005-01-01 – 2005-03-31 Source
Revenue: 680000 USD · 2005-04-01 – 2005-06-30 Source
Revenue: 1097000 USD · 2005-07-01 – 2005-09-30 Source

Net income

-16.4 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Net income: -17425000 USD · 2004-01-01 – 2004-12-31 Source
Net income: -12566000 USD · 2004-01-01 – 2004-09-30 Source
Net income: -4075000 USD · 2005-01-01 – 2005-03-31 Source
Net income: -4231000 USD · 2005-04-01 – 2005-06-30 Source
Net income: -3283000 USD · 2005-07-01 – 2005-09-30 Source

Operating cash flow

-10.7 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Operating cash flow: -14566000 USD · 2004-01-01 – 2004-12-31 Source
Operating cash flow: -11287000 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -3074000 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -6129000 USD · 2005-01-01 – 2005-06-30 Source
Operating cash flow: -3074000 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -7406000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -6129000 USD · 2005-01-01 – 2005-06-30 Source

Capital expenditure

478 thousand USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Capital expenditure: 761000 USD · 2004-01-01 – 2004-12-31 Source
Capital expenditure: 434000 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 126000 USD · 2005-01-01 – 2005-03-31 Source
Capital expenditure: 136000 USD · 2005-01-01 – 2005-06-30 Source
Capital expenditure: 126000 USD · 2005-01-01 – 2005-03-31 Source
Capital expenditure: 151000 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 136000 USD · 2005-01-01 – 2005-06-30 Source

Free cash flow

-11.2 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Operating cash flow: -14566000 USD · 2004-01-01 – 2004-12-31 Source
Operating cash flow: -11287000 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -3074000 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -6129000 USD · 2005-01-01 – 2005-06-30 Source
Operating cash flow: -3074000 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -7406000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -6129000 USD · 2005-01-01 – 2005-06-30 Source
Capital expenditure: 761000 USD · 2004-01-01 – 2004-12-31 Source
Capital expenditure: 434000 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 126000 USD · 2005-01-01 – 2005-03-31 Source
Capital expenditure: 136000 USD · 2005-01-01 – 2005-06-30 Source
Capital expenditure: 126000 USD · 2005-01-01 – 2005-03-31 Source
Capital expenditure: 151000 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 136000 USD · 2005-01-01 – 2005-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-11-18.

Financial data available through: 2004-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2004-12-31
Operating income: 7 of 11 periods available· newest 2004-12-31
Net income: 7 of 11 periods available· newest 2004-12-31
Operating cash flow: 7 of 11 periods available· newest 2004-12-31
Capital expenditure: 7 of 11 periods available· newest 2004-12-31
Total assets: 2 of 11 periods available· newest 2000-12-31
Total liabilities: 6 of 11 periods available· newest 2004-12-31
Current assets: 6 of 11 periods available· newest 2004-12-31
Current liabilities: 6 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-50.5%

Prior period

USD 3.57 million

2003-01-01 – 2003-12-31
Current period

USD 1.77 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

1767000 − 3570000 = -1803000 USD

3570000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
1767000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Year-over-year change in Revenue: -1803000 USD Concept: fundies:Revenue Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1767000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#4962 Input fundies:Revenue: 3570000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#4962
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 7.87 million

Prior period

−USD 25.29 million

2003-01-01 – 2003-12-31
Current period

−USD 17.43 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-17425000 − -25293000 = 7868000 USD

-25293000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-17425000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Year-over-year change in Net income: 7868000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -17425000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6197 Input fundies:NetIncome: -25293000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6197
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 641,000

Prior period

−USD 15.21 million

2003-01-01 – 2003-12-31
Current period

−USD 14.57 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-14566000 − -15207000 = 641000 USD

-15207000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-14566000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Year-over-year change in Operating cash flow: 641000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14566000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 Input fundies:OperatingCashFlow: -15207000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+816.9%

Prior period

USD 83,000

2003-01-01 – 2003-12-31
Current period

USD 761,000

2004-01-01 – 2004-12-31

Exact inputs and evidence

761000 − 83000 = 678000 USD

83000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
761000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Year-over-year change in Capital expenditure: 678000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 761000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 Input fundies:CapitalExpenditure: 83000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 1.77 million 100% of revenue
Operating costs Derived USD 19.24 million 1,089% of revenue
Operating income −USD 17.47 million −989% of revenue
Tax, interest and other Derived −USD 49,000 −2.8% of revenue
Net income −USD 17.43 million −986% of revenue

Cash

Operating cash flow −USD 14.57 million −824% of revenue
Capital expenditure USD 761,000 43% of revenue
Free cash flow Derived −USD 15.33 million −867% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 328% of revenue.
1999 Operating loss: operating costs were 283% of revenue.
2000 Operating loss: operating costs were 176% of revenue.
2001 Operating loss: operating costs were 234% of revenue.
2002 Operating loss: operating costs were 1,392% of revenue.
2003 Operating loss: operating costs were 813% of revenue.
2004 Operating loss: operating costs were 1,089% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	3394000	11140000 Derived	-7746000	1009000 Derived	-8755000	-3264000 Derived	Source 1998-01-01 – 1998-12-31: 3394000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -7746000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -8755000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 547000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 3811000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	16090000	45592000 Derived	-29502000	5393000 Derived	-34895000	1237000 Derived	Source 1999-01-01 – 1999-12-31: 16090000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -29502000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -34895000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 6298000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 5061000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	23291000	41072000 Derived	-17781000	-1481000 Derived	-16300000	-17486000 Derived	Source 2000-01-01 – 2000-12-31: 23291000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -17781000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -16300000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -12997000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 4489000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	17731000	41531000 Derived	-23800000	-3111000 Derived	-20689000	-30732000 Derived	Source 2001-01-01 – 2001-12-31: 17731000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -23800000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -20689000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -18451000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 12281000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	2622000	36496000 Derived	-33874000	-690000 Derived	-33184000	-24900000 Derived	Source 2002-01-01 – 2002-12-31: 2622000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -33874000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -33184000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -23932000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 968000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	3570000	29040000 Derived	-25470000	-177000 Derived	-25293000	-15290000 Derived	Source 2003-01-01 – 2003-12-31: 3570000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -25470000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -25293000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -15207000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 83000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	1767000	19241000 Derived	-17474000	-49000 Derived	-17425000	-15327000 Derived	Source 2004-01-01 – 2004-12-31: 1767000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -17474000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -17425000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -14566000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 761000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.8M 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	3394000	Revenue: 3394000 Open source
19991999-12-31	Revenue	16090000	Revenue: 16090000 Open source
20002000-12-31	Revenue	23291000	Revenue: 23291000 Open source
20012001-12-31	Revenue	17731000	Revenue: 17731000 Open source
20022002-12-31	Revenue	2622000	Revenue: 2622000 Open source
20032003-12-31	Revenue	3570000	Revenue: 3570000 Open source
20042004-12-31	Revenue	1767000	Revenue: 1767000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-50.5% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 3394000 Open source
19991999-12-31	Year over year	374.1%	Revenue: 16090000 Open source Revenue: 3394000 Open source
20002000-12-31	Year over year	44.8%	Revenue: 23291000 Open source Revenue: 16090000 Open source
20012001-12-31	Year over year	-23.9%	Revenue: 17731000 Open source Revenue: 23291000 Open source
20022002-12-31	Year over year	-85.2%	Revenue: 2622000 Open source Revenue: 17731000 Open source
20032003-12-31	Year over year	36.2%	Revenue: 3570000 Open source Revenue: 2622000 Open source
20042004-12-31	Year over year	-50.5%	Revenue: 1767000 Open source Revenue: 3570000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -988.9% 2004

Net margin -986.1% 2004

Free cash flow margin -867.4% 2004

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-228.2%	Operating Income: -7746000 Open source Revenue: 3394000 Open source
19991999-12-31	Operating margin	-183.4%	Operating Income: -29502000 Open source Revenue: 16090000 Open source
20002000-12-31	Operating margin	-76.3%	Operating Income: -17781000 Open source Revenue: 23291000 Open source
20012001-12-31	Operating margin	-134.2%	Operating Income: -23800000 Open source Revenue: 17731000 Open source
20022002-12-31	Operating margin	-1,291.9%	Operating Income: -33874000 Open source Revenue: 2622000 Open source
20032003-12-31	Operating margin	-713.4%	Operating Income: -25470000 Open source Revenue: 3570000 Open source
20042004-12-31	Operating margin	-988.9%	Operating Income: -17474000 Open source Revenue: 1767000 Open source
19981998-12-31	Net margin	-258%	Net Income: -8755000 Open source Revenue: 3394000 Open source
19991999-12-31	Net margin	-216.9%	Net Income: -34895000 Open source Revenue: 16090000 Open source
20002000-12-31	Net margin	-70%	Net Income: -16300000 Open source Revenue: 23291000 Open source
20012001-12-31	Net margin	-116.7%	Net Income: -20689000 Open source Revenue: 17731000 Open source
20022002-12-31	Net margin	-1,265.6%	Net Income: -33184000 Open source Revenue: 2622000 Open source
20032003-12-31	Net margin	-708.5%	Net Income: -25293000 Open source Revenue: 3570000 Open source
20042004-12-31	Net margin	-986.1%	Net Income: -17425000 Open source Revenue: 1767000 Open source
19981998-12-31	Free cash flow margin	-96.2%	Revenue: 3394000 Open source Operating Cash Flow: 547000 Open source Capital Expenditure: 3811000 Open source
19991999-12-31	Free cash flow margin	7.7%	Revenue: 16090000 Open source Operating Cash Flow: 6298000 Open source Capital Expenditure: 5061000 Open source
20002000-12-31	Free cash flow margin	-75.1%	Revenue: 23291000 Open source Operating Cash Flow: -12997000 Open source Capital Expenditure: 4489000 Open source
20012001-12-31	Free cash flow margin	-173.3%	Revenue: 17731000 Open source Operating Cash Flow: -18451000 Open source Capital Expenditure: 12281000 Open source
20022002-12-31	Free cash flow margin	-949.7%	Revenue: 2622000 Open source Operating Cash Flow: -23932000 Open source Capital Expenditure: 968000 Open source
20032003-12-31	Free cash flow margin	-428.3%	Revenue: 3570000 Open source Operating Cash Flow: -15207000 Open source Capital Expenditure: 83000 Open source
20042004-12-31	Free cash flow margin	-867.4%	Revenue: 1767000 Open source Operating Cash Flow: -14566000 Open source Capital Expenditure: 761000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.6M 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	547000	Operating Cash Flow: 547000 Open source
19991999-12-31	Operating cash flow	6298000	Operating Cash Flow: 6298000 Open source
20002000-12-31	Operating cash flow	-12997000	Operating Cash Flow: -12997000 Open source
20012001-12-31	Operating cash flow	-18451000	Operating Cash Flow: -18451000 Open source
20022002-12-31	Operating cash flow	-23932000	Operating Cash Flow: -23932000 Open source
20032003-12-31	Operating cash flow	-15207000	Operating Cash Flow: -15207000 Open source
20042004-12-31	Operating cash flow	-14566000	Operating Cash Flow: -14566000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.3M 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-3264000	Operating Cash Flow: 547000 Open source Capital Expenditure: 3811000 Open source
19991999-12-31	Free cash flow	1237000	Operating Cash Flow: 6298000 Open source Capital Expenditure: 5061000 Open source
20002000-12-31	Free cash flow	-17486000	Operating Cash Flow: -12997000 Open source Capital Expenditure: 4489000 Open source
20012001-12-31	Free cash flow	-30732000	Operating Cash Flow: -18451000 Open source Capital Expenditure: 12281000 Open source
20022002-12-31	Free cash flow	-24900000	Operating Cash Flow: -23932000 Open source Capital Expenditure: 968000 Open source
20032003-12-31	Free cash flow	-15290000	Operating Cash Flow: -15207000 Open source Capital Expenditure: 83000 Open source
20042004-12-31	Free cash flow	-15327000	Operating Cash Flow: -14566000 Open source Capital Expenditure: 761000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

16% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
19991999-12-31	Liabilities / assets	121.1%	Total Liabilities: 38465000 Open source Total Assets: 31762000 Open source
20002000-12-31	Liabilities / assets	16%	Total Liabilities: 17151000 Open source Total Assets: 106943000 Open source
20012001-12-31	Liabilities / assets	Not reported	Total Liabilities: 3875000 Open source
20022002-12-31	Liabilities / assets	Not reported	Total Liabilities: 2082000 Open source
20032003-12-31	Liabilities / assets	Not reported	Total Liabilities: 2661000 Open source
20042004-12-31	Liabilities / assets	Not reported	Total Liabilities: 3364000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.56× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	0.91×	Current Assets: 15216000 Open source Current Liabilities: 16730000 Open source
20002000-12-31	Current assets / current liabilities	5.41×	Current Assets: 86924000 Open source Current Liabilities: 16071000 Open source
20012001-12-31	Current assets / current liabilities	15.12×	Current Assets: 49996000 Open source Current Liabilities: 3306000 Open source
20022002-12-31	Current assets / current liabilities	13.51×	Current Assets: 24607000 Open source Current Liabilities: 1821000 Open source
20032003-12-31	Current assets / current liabilities	4.99×	Current Assets: 8708000 Open source Current Liabilities: 1744000 Open source
20042004-12-31	Current assets / current liabilities	1.56×	Current Assets: 1766000 Open source Current Liabilities: 1130000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 8.76 million Exact value Exact value: -8755000 USD 1998-01-01 – 1998-12-31: -8755000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 1998-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -8755000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8755000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001095811-01-001996.txt#9869 The citation records this snapshot. The page link may show a newer release later.	USD 547,000 Exact value Exact value: 547000 USD 1998-01-01 – 1998-12-31: 547000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 1998-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: 547000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 547000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001095811-01-001996.txt#10339 The citation records this snapshot. The page link may show a newer release later.	USD 3.81 million Exact value Exact value: 3811000 USD 1998-01-01 – 1998-12-31: 3811000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 1998-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 3811000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3811000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001095811-01-001996.txt#9339 The citation records this snapshot. The page link may show a newer release later.	−USD 3.26 million Calculation and evidence 547000 − 3811000 USD Exact free cash flow: -3264000 USD 1998-01-01 – 1998-12-31: 547000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 3811000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 1998-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: -3264000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 547000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001095811-01-001996.txt#10339 Input fundies:CapitalExpenditure: 3811000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001095811-01-001996.txt#9339 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 34.9 million Exact value Exact value: -34895000 USD 1999-01-01 – 1999-12-31: -34895000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 1999-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -34895000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34895000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-02-001161.txt#4966 The citation records this snapshot. The page link may show a newer release later.	USD 6.3 million Exact value Exact value: 6298000 USD 1999-01-01 – 1999-12-31: 6298000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 1999-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: 6298000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6298000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-02-001161.txt#5260 The citation records this snapshot. The page link may show a newer release later.	USD 5.06 million Exact value Exact value: 5061000 USD 1999-01-01 – 1999-12-31: 5061000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 1999-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 5061000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5061000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-02-001161.txt#5331 The citation records this snapshot. The page link may show a newer release later.	USD 1.24 million Calculation and evidence 6298000 − 5061000 USD Exact free cash flow: 1237000 USD 1999-01-01 – 1999-12-31: 6298000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 5061000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 1999-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: 1237000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6298000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-02-001161.txt#5260 Input fundies:CapitalExpenditure: 5061000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-02-001161.txt#5331 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 16.3 million Exact value Exact value: -16300000 USD 2000-01-01 – 2000-12-31: -16300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 2000-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -16300000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16300000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-03-002183.txt#5545 The citation records this snapshot. The page link may show a newer release later.	−USD 13 million Exact value Exact value: -12997000 USD 2000-01-01 – 2000-12-31: -12997000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 2000-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: -12997000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12997000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-03-002183.txt#5853 The citation records this snapshot. The page link may show a newer release later.	USD 4.49 million Exact value Exact value: 4489000 USD 2000-01-01 – 2000-12-31: 4489000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 2000-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 4489000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4489000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-03-002183.txt#5923 The citation records this snapshot. The page link may show a newer release later.	−USD 17.49 million Calculation and evidence -12997000 − 4489000 USD Exact free cash flow: -17486000 USD 2000-01-01 – 2000-12-31: -12997000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 4489000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 2000-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: -17486000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12997000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-03-002183.txt#5853 Input fundies:CapitalExpenditure: 4489000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0000898430-03-002183.txt#5923 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 20.69 million Exact value Exact value: -20689000 USD 2001-01-01 – 2001-12-31: -20689000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 2001-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -20689000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20689000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001193125-04-053476.txt#6479 The citation records this snapshot. The page link may show a newer release later.	−USD 18.45 million Exact value Exact value: -18451000 USD 2001-01-01 – 2001-12-31: -18451000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 2001-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: -18451000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18451000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001193125-04-053476.txt#6801 The citation records this snapshot. The page link may show a newer release later.	USD 12.28 million Exact value Exact value: 12281000 USD 2001-01-01 – 2001-12-31: 12281000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 2001-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 12281000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12281000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001193125-04-053476.txt#6871 The citation records this snapshot. The page link may show a newer release later.	−USD 30.73 million Calculation and evidence -18451000 − 12281000 USD Exact free cash flow: -30732000 USD 2001-01-01 – 2001-12-31: -18451000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 12281000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 2001-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: -30732000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18451000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001193125-04-053476.txt#6801 Input fundies:CapitalExpenditure: 12281000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001193125-04-053476.txt#6871 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 33.18 million Exact value Exact value: -33184000 USD 2002-01-01 – 2002-12-31: -33184000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 2002-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -33184000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33184000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6197 The citation records this snapshot. The page link may show a newer release later.	−USD 23.93 million Exact value Exact value: -23932000 USD 2002-01-01 – 2002-12-31: -23932000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 2002-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: -23932000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23932000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 The citation records this snapshot. The page link may show a newer release later.	USD 968,000 Exact value Exact value: 968000 USD 2002-01-01 – 2002-12-31: 968000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 2002-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 968000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 968000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 The citation records this snapshot. The page link may show a newer release later.	−USD 24.9 million Calculation and evidence -23932000 − 968000 USD Exact free cash flow: -24900000 USD 2002-01-01 – 2002-12-31: -23932000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 968000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 2002-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: -24900000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23932000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 Input fundies:CapitalExpenditure: 968000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 25.29 million Exact value Exact value: -25293000 USD 2003-01-01 – 2003-12-31: -25293000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 2003-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -25293000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25293000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6197 The citation records this snapshot. The page link may show a newer release later.	−USD 15.21 million Exact value Exact value: -15207000 USD 2003-01-01 – 2003-12-31: -15207000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 2003-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: -15207000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15207000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 The citation records this snapshot. The page link may show a newer release later.	USD 83,000 Exact value Exact value: 83000 USD 2003-01-01 – 2003-12-31: 83000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 2003-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 83000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 83000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 The citation records this snapshot. The page link may show a newer release later.	−USD 15.29 million Calculation and evidence -15207000 − 83000 USD Exact free cash flow: -15290000 USD 2003-01-01 – 2003-12-31: -15207000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 83000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 2003-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: -15290000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15207000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 Input fundies:CapitalExpenditure: 83000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 17.43 million Exact value Exact value: -17425000 USD 2004-01-01 – 2004-12-31: -17425000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Net Income: -17425000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17425000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6197 The citation records this snapshot. The page link may show a newer release later.	−USD 14.57 million Exact value Exact value: -14566000 USD 2004-01-01 – 2004-12-31: -14566000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Operating Cash Flow: -14566000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14566000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 The citation records this snapshot. The page link may show a newer release later.	USD 761,000 Exact value Exact value: 761000 USD 2004-01-01 – 2004-12-31: 761000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Capital Expenditure: 761000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 761000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 The citation records this snapshot. The page link may show a newer release later.	−USD 15.33 million Calculation and evidence -14566000 − 761000 USD Exact free cash flow: -15327000 USD 2004-01-01 – 2004-12-31: -14566000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 761000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LARGE SCALE BIOLOGY CORP · 2004-12-31 LARGE SCALE BIOLOGY CORP (edgar:1108951) Free cash flow: -15327000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:30:30Z Snapshot: a58e9e477a73b773a1314f1ffbcc21eb1a32375c39fa9b04d8a1e99f64f8f5a3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108951?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14566000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6565 Input fundies:CapitalExpenditure: 761000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108951/0001047469-05-010393.txt#6647 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

23 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001108951, 1108951, edgar:1108951

LARGE SCALE BIOLOGY CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation